throbber
THE CANCER DICTIONARY
`
`\
`
`Roberta Altman
`
`Michael J. Sarg, MD.
`
`Associate Chief of Medical Oncology,
`St. Vincent’s Hospital, New York City
`
`Associate Professor of Clinical Medicine,
`New York Medical College
`
`I?
`FactsOnFlle
`
`AN INFOBASE HOLDlNGS COMPANY
`
`NOVARTIS EXHIBIT 2004
`Breckenridge V. Novattis, IPR 2017-01592
`Page 1 of 5
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 1 of 5
`
`

`

`The Cancer Dictionary
`
`Copyright © 1992 by Roberta Altman and Michael]. Sarg, M.D.
`
`All rights reserved. No part of this book may be reproduced or utilized in any form
`or by any means, electronic or mechanical, including photocopying, recording, or
`by any information storage or retrieval systems, without permission in writing
`from the publisher. For information contact:
`
`Facts On File, Inc.
`460 Park Avenue South
`
`New York, NY 10016
`
`Library of Congress Cataloging-in—Publication Data
`
`Altman, Roberta
`
`The cancer dictionary / Roberta Altman, Michael Sarg.
`p.
`cm.
`
`Includes Bibliographical references and index.
`ISBN 0—8160-2608-4 (hc/alk. paper)
`ISBN 0-8160-3027-8 (pb)
`11. Title.
`l. Cancer—Dictionaries.
`I. Sarg, Michael.
`[DNLMz 1. Neoplasms—dictionaries. Q2 13 A468c]
`RC262.A39
`1992.
`616.99'4’003—dc20
`DNLM/DLC
`
`for Library of Congress
`
`91-46941
`
`Facts On File books are available at special discounts when purchased in bulk
`quantities for businesses, associations, institutions, or sales promotions.
`Please contact our Special Sales Department in New York at 212/683-2244
`or 800/322-8755.
`
`Text design by Ron Monteleone
`Jacket design by Mary McKenna-Ridge
`Composition by the Maple-Vail Book Manufacturing Group
`Manufactured by Hamilton Printing Company
`Printed in the United States of America
`
`109876543
`
`This book is printed on acid-free paper.
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 2 of 5
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 2 of 5
`
`

`

`51
`cancer
`’______________________.__—__.
`
`removed but do not require a STOMA. A section of
`the ileum (lower part of the small intestine) is re-
`moved during surgery; one end is attached to the
`URETERS and the other is connected to the remainder
`of the urethra, forming a canal for the urine. To avoid
`1eakage, the person must urinate frequently.
`
`cAMP a combination of the anticancer drugs CY-
`TOXAN, ADRIAMYCIN, METHOTREXATE, and PROCARBA-
`ZINE sometimes used in the treatment of NONSMALL
`CELL LUNG CANCER. See individual drug listings for
`side effects. See also COMBINATION CHEMOTHERAPY.
`
`cancer a general term for more than 100 diseases
`characterized by the uncontrolled, abnormal growth
`of cells in different parts of the body that can spread
`to other parts of the body. Different cancers have
`“unique" characteristics
`requiring different
`treat-
`ments. Cancer is frequently a chronic—that is, re-
`curring——disease.
`Cancer has been around for centuries. Evidence of
`cancer has been found in skeletons of prehistoric
`animals and in Etruscan, Peruvian, and Egyptian
`mummies. A link between the environment and a
`
`tumor was first observed in England in 1775 by
`Percival Pott, who found that cancer of the scrotum
`appeared frequently in chimney sweeps in London.
`Today, cancer is classified into five major groups:
`
`- CARCINOMA—a cancerous tumor or lump, originat-
`ing in the surface tissue of body organs. It is the
`most common form of cancer, accounting for 80 to
`90% of cases
`
`' SARCOMA—a cancerous tumor originating in the
`bone, cartilage, muscle, fibrous connective tissue,
`or fatty tissue
`° MYELOMA—a cancerous tumor originating in the
`plasma cells of the BONE MARROW
`' LYMPHOMA—a cancerous tumor originating in the
`lymph system
`' LEUKEMIA—cancer originating in the blood-forming
`tissue.
`
`Cancer cells cause harm in a number of different
`
`ways. They deprive normal cells of nourishment or
`Space. They can form a mass, or tumor, which may
`eventually invade and destroy normal tissues. They
`can also spread (metastasize) by traveling through
`the bloodstream or lymphatic system to other parts
`of the body.
`
`Most cancers take years to develop. For example,
`lung cancer used to be fairly rare among women.
`After World War 11, millions of women started smok—
`
`ing when it became “socially acceptable.” About 40
`years later, lung cancer replaced breast cancer as the
`leading cause of death from cancer among women.
`Cancer that
`is detected and treated before it has
`
`invaded adjacent organs or metastasized has the greatest
`possibility of being cured.
`The risk of cancer increases as one ages. However,
`it can affect males and females of any age, any social
`class, and any nationality.
`There were more than 1,040,000 new cases of
`
`cancer diagnosed in the United States in 1990 (not
`including carcinoma IN SITU and nonmelanoma skin
`cancer) and about 500,000 deaths. In the early 19005
`most people who got cancer died within a few years.
`By the 19305 one person in five lived five or more
`years after being treated. That changed to one in four
`in the 19405, and one in three in the 19505. In 1990
`it was four in ten, or 40%. However, when normal
`
`life expectancy is taken into account, the relative five—
`year survival rate is 50%.
`Different cancers have different symptoms. The
`American Cancer Society has a general list of seven
`basic symptoms that could be warning signs of can-
`cer:
`
`1. unusual bleeding or discharge
`2. a lump that does not go away
`3. a sore that does not heal within two weeks
`
`4.; change in bowel or bladder habits
`5. persistent hoarseness or cough
`6.
`indigestion or difficulty in swallowing
`7. change in a wart or mole.
`
`These symptoms can also occur in many other
`conditions. If they persist, medical attention should
`be sought.
`There are four types of treatment for cancer. In the
`early 19005, SURGERY was the only known treatment
`for cancer. In the 19305, radium (RADIATION THERAPY)
`
`was recognized as an effective treatment for cancer.
`CHEMOTHERAPY (anticancer drugs) was first used in
`the 19505, when it successfully treated choriocarci—
`noma, a gynecological cancer. Treatment became in-
`creasingly more effective as combinations of surgery,
`radiation, and chemotherapy became more common
`in the treatment of different cancers. The 19703 and
`
`19805 saw the increasing development of immuno-
`therapy or BIOLOGICAL THERAPY. Although this type of
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 3 of 5
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 3 of 5
`
`

`

`
`
`52 cancer genes
`
`treatment is still in its earliest stage, many researchers
`are optimistic that
`the continuing investigation of
`biological therapy will find ways for the body’s own
`IMMUNE SYSTEM to fight successfully the cancer battle
`within it.
`
`Another focus of continuing research is the devel-
`opment of new diagnostic tests, and the refinement
`of tests already in use, that detect cancer in its earliest
`stage and accurately show where in the body it has
`spread and that can assess the possibility that the
`cancer will recur, or return, after it has been treated.
`
`Some of the newer techniques and tests being studied
`include using high-frequency sound waves to pro-
`duce detailed pictures of structures in the body;
`measuring minute differences of heat in the body to
`locate cancer; and using TUMOR MARKERS, biological
`substances in the body that can indicate the presence
`of cancer.
`
`Finally, scientists continue to search for the causes
`of cancer and ways to prevent it. Some researchers
`theorize that cancer cells are always present in the
`body and that the immune system is always fighting
`them off until something goes wrong, and one area
`being heavily researched is the role that genes play
`in the development of cancer (and in its treatment).
`Scientists are also trying to identify additional CAR-
`CINOGENS, agents that cause cancer. One carcinogen
`that has been known about
`for years is cigarette
`smoke. It is well documented that smoking puts a
`person at a much greater risk of getting lung cancer
`as well as other cancers. Some foods and vitamins,
`
`such as beta carotene and fiber, are being investigated
`for their role in preventing cancer.
`See subject index for types of cancers, symptoms,
`side effects, drug treatments, and other major topics
`included in this volume.
`
`cancer genes see ONCOGENE.
`
`cancer registry see TUMOR REGISTRY.
`
`CAP a combination of the anticancer drugs CISPLA-
`TIN, ADRIAMYCIN, and CYTOXAN sometimes used in the
`treatment of NONSMALL CELL LUNG CANCER and cancer
`
`of the kidney, bladder, and prostate. See individual
`listings for side effects. See also COMBINATION CHE-
`MOTHERAPY.
`
`carbohydrate antigen see CA 19-9.
`
`carbon dioxide laser a laser that uses carbon diox-
`
`ide to produce a powerful light beam. In LASER THER-
`APY for cancer, the carbon dioxide laser is primarily
`used as a surgical tool. The carbon dioxide laser is
`used to shrink or destroy tumors. The light energy
`changes to heat and cuts or vaporizes cancerous tissue
`with relatively little bleeding. When it is used with
`an ENDOSCOPE, the laser‘s light is transmitted through
`the flexible endoscope, enabling the surgeon to see
`and work, with great precision, in parts of the body
`that otherwise could only be reached with traditional
`surgery.
`
`carboplatin (kaf’bo-pla’tin) [CBDCA, JM-8, Para-
`platin, cyclobutan dicarboxyiate platinum] an-AL-
`KYLATING anticancer drug, which in the late 19805
`and early 19905 was considered the drug of choice
`in the treatment of OVARIAN CANCER. It is also used
`
`in a variety of other cancers, including cancer of the
`lung, head, and neck.
`It was designed to be as
`effective as CISPLATIN, the parent compound, with less
`toxicity.
`It
`is given by IV (injection into a vein).
`Possible side effects are severe nausea and vomiting,
`BONE MARROW DEPRESSION, ANEMIA, kidney problems,
`and neurological damage. Carboplatin is one of the
`more important anticancer drugs in use.
`
`carboxamide see DTIC.
`
`carcinoembryonic antigen see CEA.
`
`carcinogens (kar—sin’-0-jenz) substances known to
`cause and/or promote cancer. Carcinogens can be
`created by humans, such as cigarette smoke, or sim-
`ply be present naturally in the environment, as is
`ULTRAVIOLET RADIATION from the sun, both of which
`
`are known to play a major role in the development
`of cancer. x RAYS and VIRUSES are also known carcin-
`ogens.
`
`Carcinogens can work to cause cancer in different
`ways. Some cause changes that turn a normal cell in
`the body into a cancer cell. Others can set up con-
`ditions that help the action of other factors that cause
`the cancer.
`
`Many cancers develop slowly. It can take from 5
`to 40 years for cancer to develop after exposure to a
`cancer-causing agent, making it difficult to identify
`carcinogens. The number of exposures and the length
`of time exposed to a carcinogen are two of the factors
`that play a role in when and if cancer will develop.
`
`NOVARTIS EXHIBIT 2004
`Breckenridge V. Novartis, IPR 2017-01592
`Page 4 of 5
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 4 of 5
`
`

`

`Treatment IN D
`2 78
`——_—_———_—____“~\
`
`Treatment IND (investigational new drug) a pro-
`gram of the Food and Drug Administration that
`makes certain experimental drugs available to seri-
`ously ill people, generally people for whom there is
`no other available treatment. Drug companies may
`charge for the drug. See COMPASSIONATE DRUG.
`
`treatment port see EXTERNAL RADIATION THERAPY.
`
`triamcinolone see ADRENOCORTICOIDS.
`
`triazinate [TZT, Baker’s antifol, ethansulfonic acid
`compound] an anticancer drug being investigated
`for its use in the treatment of cancers of the brain,
`kidney, stomach, breast, colon, and lung. It is ad-
`ministered by lV (injection into a vein). Common
`side effects may include nausea, vomiting, BONE MAR—
`ROW DEPRESSION, skin darkening, skin rashes, mouth
`sores, and diarrhea. Occasional and rare side effects
`
`may include visual disturbances and headaches.
`
`triethylene thiophosphora see THIOTEPA.
`
`true cords see VOCAL CORDs.
`
`TSE see TESTICULAR SELF-EXAMINATION.
`
`TSEB see TOTAL SKIN ELECTRON BEAM RADIATION
`THERAPY.
`
`TSH see THYROID STIMULATING HORMONE.
`
`TSPA see THIOTEPA.
`
`tubular ductal breast cancer a relatively rare form
`of BREAST CANCER occurring about 1% of the time.
`The tumor has tube-shaped structures ringed with a
`single layer of cells. It is a well-differentiated carci-
`noma. It generally has a favorable PROGNOSIs.
`
`tubulovillous polyps see INTERMEDIATE POLYPS.
`
`tumor an abnormal tissue growth or mass on or in
`the body that serves no useful purpose. A tumor can
`be benign (noncancerous) or malignant (cancerous).
`It can be a MIXED TUMOR, meaning it has two or more
`cell types. Most tumors do not become cancerous.
`Following are the characteristics that distinguish a
`benign tumor from a malignant tumor:
`
`- a benign tumor grows slowly, has limited growrh
`and does not destroy normal cells; a malignant
`tumor grows rapidly, destroys normal cells, and has
`unlimited growth potential
`- a benign tumor continues to grow in the place Where
`it originated; a malignant tumor can spread to Other
`parts of the body
`° a benign tumor usually does not have serious side
`effects (the major exception being brain tumors
`which grow in a confined space); malignant tumors
`are life threatening
`- benign tumors grow in an orderly way; malignant
`tumors grow in a disorderly way, unpredictably.
`
`Some tumors are characterized as precancerous,
`Precancerous tumors do not always become cancer-
`ous, but they Should be removed, if possible, to avert
`the possibility of cancer developing.
`
`tumor barrier barriers developed by tumors that
`prevent chemotherapy (anticancer drugs) from reach-
`ing many of the cancer cells in the tumor. An example
`of a barrier would be an area of collapsed blood
`vessels. The anticancer drugs that travel through the
`bloodstream would not be able to reach an area with
`few or no normal blood vessels. Therefore, the che-
`motherapy may be able to destroy the outer parts of
`the tumor but would not be able to eradicate the
`entire tumor.
`
`tumor debulking surgical removal of as much of a
`tumor as possible.
`
`tumor embolization (em”bo-li-za’shun) obstruc-
`tion of blood vessels by a tumor. This condition can
`prevent chemotherapy (anticancer drugs) from reach-
`ing parts of the tumor.
`
`tumor growth factors (TGF) hormone-like proteins
`secreted by a cancerous tumor that stimulate the
`growth of identical cancer cells. MONOCLONAL ANTI-
`BODIES can bind to the substances and inactivate
`them. Researchers have identified TGF associated
`
`with different cancers. For example, TFG-alpha, epi-
`dermal growth factor, and fibroblast growth factors
`are produced by human breast cancer cells that have
`been stimulated by estrogen.
`
`lymphocytes,
`tumor infiltrating lymphocytes (TIL)
`a type of WHITE BLOOD CELL,
`that can invade or
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 5 of 5
`
`NOVARTIS EXHIBIT 2004
`Breckenridge v. Novartis, IPR 2017-01592
`Page 5 of 5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket